LC
ISPC icon

Lindbrook Capital’s iSpecimen ISPC Stock Holding History

Lindbrook Capital’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6
Closed -$36K – 1923
2021
Q2 		$36K Buy
+6
New +$34.5K 0.01% 575

Other funds holding ISPC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Telemus Capital Southfield, Michigan $1.21B AUM 23.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

Lindbrook Capital's ISPC Position: Q3 2021 in Review

Lindbrook Capital sold out of iSpecimen (ISPC) in Q3 2021, closing a stake of 6 shares — an estimated $36K sold.

Lindbrook Capital first reported a position in ISPC in Q2 2021 and held it in 1 quarter. The position peaked at $36K in Q2 2021. 8 funds tracked by Wall St. Rank hold ISPC as of Q3 2021.

  • Lindbrook Capital reported no remaining iSpecimen position as of Q3 2021 after selling out during the quarter.
  • Lindbrook Capital sold 6 iSpecimen shares in Q3 2021, an estimated $36K.
  • Lindbrook Capital first reported a position in iSpecimen in Q2 2021 and held it in 1 quarter.
  • Lindbrook Capital's iSpecimen position peaked at $36K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held iSpecimen as of Q3 2021.

Based on Lindbrook Capital's 13F filing for Q3 2021, filed 5 Nov 2021.